Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
budesonide + terbutaline
- Development stage
- Phase 3
- Lead developer
- AstraZeneca
- Modality
- Small Molecules
- Administration
- Inhalation, Oral, Intravenous, Subcutaneous, Intranasal, Rectal
01
Overview
Budesonide + terbutaline is a combination of two small molecule drugs used primarily for respiratory conditions. Budesonide is a synthetic glucocorticoid corticosteroid that acts as an anti-inflammatory agent, reducing inflammation in the airways and other tissues. Terbutaline is a selective beta-2 adrenergic receptor agonist that functions as a bronchodilator by relaxing smooth muscle in the bronchial tubes, thereby improving airflow and relieving symptoms such as wheezing and shortness of breath. This combination may be considered for use in asthma or chronic obstructive pulmonary disease (COPD), leveraging both anti-inflammatory and bronchodilatory effects[1][2][5].
- Brand names
- AirsupraBreynaBreztriCortimentPulmicort TurbuhalerRhinocortSymbicortBricanyl
02
Targets
ADRB2 (β2)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on budesonide + terbutaline.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on budesonide + terbutaline.